PJ

Prashansa Jaahnwi

Active Director Director DIN 10881070
DIN 10881070 First appointment Dec 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Prashansa Jaahnwi

Data last updated:

Prashansa Jaahnwi is a Director at Gynexis Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10881070
Primary Designation Director
Industry Pharma
First Appointment 04 Dec 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Dec 20242024Active

Board colleagues of Prashansa Jaahnwi

Directorship timeline

Open interactive timeline →
Gynexis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prashansa Jaahnwi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashansa Jaahnwi

Prashansa Jaahnwi currently holds 1 directorship: Gynexis Pharmaceuticals Private Limited (Director, since 04 Dec 2024).

Prashansa Jaahnwi was first appointed on 04 Dec 2024 as Director at Gynexis Pharmaceuticals Private Limited.

The current boards of Prashansa Jaahnwi's companies include Niti Kumari (Gynexis Pharmaceuticals Private Limited), Preeti Kumari (Gynexis Pharmaceuticals Private Limited), Vaishnavi Shreya Jha (Gynexis Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available